A major current clinical problem in trauma and emergency general surgery is the monitoring and reversal of patients taking novel oral anticoagulants who present with bleeding or the need for intervention. As part of an industry sponsored trial, we are investigating the role of TEG to detect Factor Xa inhibition and determine whether novel TEG based strategies can be used to detect/screen for NOAC use.